People: Guided Therapeutics Inc (GTHP.OB)

GTHP.OB on OTC BB

0.22USD
19 Dec 2014
Price Change (% chg)

$-0.00 (-2.22%)
Prev Close
$0.22
Open
$0.22
Day's High
$0.22
Day's Low
$0.22
Volume
188,486
Avg. Vol
219,299
52-wk High
$0.63
52-wk Low
$0.20

Search Stocks

Hart, Ronald 

Brief Biography

Dr. Ronald W. Hart, Ph.D., is Independent Vice Chairman and Director of Guided Therapeutics Inc. He has served as a member of the board since March 2007 and was elected Vice Chairman in 2011. He has published 600 peer-reviewed publications, has been appointed to a number of academic positions and is credited with developing the first direct proof that DNA is causal in certain forms of cancer. He chaired a number of federal committees and task forces, including the development and implementation of the Technology Transfer Act of 1986 and the White House Task Force on Chemical Carcinogenesis. In 1980, Dr. Hart was appointed Director of the National Center for Toxicological Research, the research arm of the FDA, a position he held until 1992. In 1992, Dr. Hart was the first ever Presidential Appointee to the position of Distinguished Scientist in Residence for the US Public Health Service/FDA, a position he held until his retirement in 2000. Dr. Hart received his Ph.D. in physiology and biophysics from the University of Illinois.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks